SQZ Biotechnologies Company
SQZB
$0.028
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -71.64M | -70.65M | -76.11M | -79.46M | -77.74M |
| Total Depreciation and Amortization | 11.45M | 11.54M | 11.98M | 11.68M | 11.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.47M | 5.88M | 7.14M | 8.44M | 8.99M |
| Change in Net Operating Assets | -24.61M | -28.45M | -29.90M | -24.21M | -26.06M |
| Cash from Operations | -74.33M | -81.68M | -86.89M | -83.55M | -83.81M |
| Capital Expenditure | -213.00K | -326.00K | -359.00K | -522.00K | -421.00K |
| Sale of Property, Plant, and Equipment | 170.00K | 155.00K | 0.00 | 34.00K | 34.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -43.00K | -171.00K | -359.00K | -488.00K | -387.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 331.00K | 1.00M | 4.20M | 4.23M | 4.18M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 331.00K | 1.00M | 4.20M | 4.23M | 4.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -74.05M | -80.85M | -83.04M | -79.80M | -80.02M |